Becton Dickinson and Company

-6.42%

Becton Dickinson and Company (BD) is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD was founded in 1897 by Maxwell Becton and Fairleigh Dickinson and is headquartered in Franklin Lakes, New Jersey, USA.
The company's products are used in various healthcare settings such as hospitals, clinics, laboratories, and pharmacies, to improve patient care and help healthcare professionals diagnose and treat diseases. BD's main areas of focus include diagnostic systems, medication delivery solutions, and biosciences.
BD has a presence in over 190 countries and employs more than 70,000 people worldwide. The company has a global reach in both developed and emerging markets, with a diverse product portfolio and a strong research and development pipeline.
BD is committed to enhancing healthcare outcomes through innovation and collaboration with healthcare professionals, patients, and healthcare systems. The company aims to make a positive impact on the future of healthcare by providing safe, effective, and high-quality medical products and services.
In addition, BD has a strong commitment to corporate social responsibility and sustainability. The company focuses on initiatives related to improving access to healthcare, reducing its environmental footprint, and promoting ethical business practices.
Overall, BD is a leading company in the medical technology industry, with a long history of innovation and a strong dedication to improving healthcare outcomes globally.

1. Pioneering Medical Technology: Becton Dickinson (BD) is a global leader in medical technology, developing and manufacturing innovative medical devices, equipment, and diagnostic products. The company is known for its pioneering role in introducing many medical breakthroughs that have revolutionized healthcare.
2. Broad Product Portfolio: BD has a diverse portfolio of products that span the entire healthcare continuum, from medical devices to diagnostic solutions. The company's offering includes syringes, needles, IV catheters, infusion pumps, diabetes care products, molecular diagnostics, and more.
3. Global Presence: BD has a widespread global presence, with operations in over 50 countries and products sold in more than 190 countries. This allows the company to reach a vast customer base and provide healthcare solutions to people around the world.
4. Strong Focus on Innovation: BD invests heavily in research and development, with around $1.7 billion allocated for R&D in 2019. The company's commitment to innovation has resulted in numerous patents and groundbreaking products.
5. Commitment to Sustainability: BD takes a proactive approach to sustainability, implementing environmentally responsible practices in its operations and manufacturing processes. The company is also involved in various initiatives to reduce its carbon footprint and promote sustainable healthcare solutions.
6. Corporate Social Responsibility: BD has a strong corporate social responsibility (CSR) program, focusing on addressing global health challenges, improving healthcare access and outcomes, and promoting sustainable business practices.
7. Strong Financial Performance: BD has a history of delivering strong financial performance, with consistent revenue growth and a healthy balance sheet. This has helped the company to invest in research and development and expand its global presence.
8. Award-Winning Company: BD has received numerous accolades for its advancements in medical technology, commitment to sustainability, and corporate social responsibility. The company has been recognized by top publications and organizations, including Fortune, Forbes, and Corporate Responsibility Magazine.